Mackenzie Financial’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.7M Buy
208,510
+124,793
+149% +$10.3M 0.02% 439
2025
Q4
$7.2M Buy
83,717
+12,675
+18% +$1.04M 0.01% 569
2025
Q3
$5.52M Buy
71,042
+10,395
+17% +$812K 0.01% 619
2025
Q2
$4.74M Sell
60,647
-9,670
-14% -$721K 0.01% 612
2025
Q1
$5.1M Sell
70,317
-59,528
-46% -$4.26M 0.01% 577
2024
Q4
$9.61M Buy
129,845
+23,729
+22% +$1.66M 0.01% 474
2024
Q3
$7M Buy
106,116
+14,626
+16% +$1.06M 0.01% 496
2024
Q2
$8.45M Sell
91,490
-4,014
-4% -$355K 0.01% 465
2024
Q1
$9.13M Buy
95,504
+3,422
+4% +$287K 0.01% 461
2023
Q4
$7.02M Sell
92,082
-67,034
-42% -$4.66M 0.01% 491
2023
Q3
$11.1M Buy
159,116
+19,208
+14% +$1.54M 0.02% 415
2023
Q2
$12.8M Sell
139,908
-500,463
-78% -$43.5M 0.02% 410
2023
Q1
$53M Buy
640,371
+3,803
+0.6% +$299K 0.08% 216
2022
Q4
$47.5M Sell
636,568
-76,905
-11% -$5.93M 0.08% 211
2022
Q3
$59M Buy
713,473
+24,438
+4% +$2.35M 0.1% 188
2022
Q2
$65.5M Buy
689,035
+33,468
+5% +$3.46M 0.1% 186
2022
Q1
$77.2M Buy
655,567
+19,798
+3% +$2.22M 0.1% 186
2021
Q4
$82.4M Buy
635,769
+125,610
+25% +$14.7M 0.11% 185
2021
Q3
$57.8M Buy
510,159
+13,874
+3% +$1.58M 0.08% 216
2021
Q2
$51.4M Buy
496,285
+223,316
+82% +$21M 0.07% 221
2021
Q1
$22.8M Buy
272,969
+209,696
+331% +$17.7M 0.03% 295
2020
Q4
$5.77M Buy
63,273
+6,984
+12% +$579K 0.01% 420
2020
Q3
$4.49M Sell
56,289
-17,406
-24% -$1.36M 0.01% 417
2020
Q2
$5.09M Sell
73,695
-41,841
-36% -$2.97M 0.01% 394
2020
Q1
$7.26M Buy
115,536
+78,633
+213% +$5.67M 0.02% 305
2019
Q4
$2.87M Buy
36,903
+30,156
+447% +$2.35M 0.01% 549
2019
Q3
$495K Buy
6,747
+1,866
+38% +$131K ﹤0.01% 823
2019
Q2
$301K Sell
4,881
-1,425
-23% -$86.2K ﹤0.01% 958
2019
Q1
$402K Sell
6,306
-12,063
-66% -$688K ﹤0.01% 1060
2018
Q4
$938K Sell
18,369
-11,436
-38% -$579K ﹤0.01% 819
2018
Q3
$1.73M Buy
29,805
+4,305
+17% +$211K ﹤0.01% 676
2018
Q2
$1.24M Buy
25,500
+2,271
+10% +$106K ﹤0.01% 654
2018
Q1
$1.08M Buy
23,229
+6,171
+36% +$268K ﹤0.01% 633
2017
Q4
$641K Buy
17,058
+3,987
+31% +$146K ﹤0.01% 656
2017
Q3
$476K Buy
13,071
+1,278
+11% +$48.7K ﹤0.01% 524
2017
Q2
$465K Buy
11,793
+3,585
+44% +$131K ﹤0.01% 525
2017
Q1
$257K Buy
8,208
+594
+8% +$18.6K ﹤0.01% 581
2016
Q4
$238K Buy
+7,614
New +$247K ﹤0.01% 585
2016
Q3
Sell
-24,498
Closed -$814K 722
2016
Q2
$814K Buy
24,498
+1,398
+6% +$47.8K ﹤0.01% 650
2016
Q1
$679K Sell
23,100
-65,700
-74% -$1.81M 0.01% 599
2015
Q4
$2.34M Buy
88,800
+48,600
+121% +$1.26M 0.01% 387
2015
Q3
$953K Buy
40,200
+21,198
+112% +$512K 0.01% 547
2015
Q2
$451K Buy
19,002
+2,958
+18% +$66.8K ﹤0.01% 690
2015
Q1
$381K Buy
+16,044
New +$360K ﹤0.01% 703
2014
Q4
Sell
-3,731,400
Closed -$63.5M 750
2014
Q3
$63.5M Sell
3,731,400
-712,200
-16% -$11.2M 0.32% 70
2014
Q2
$63.6M Sell
4,443,600
-1,667,400
-27% -$22.6M 0.3% 79
2014
Q1
$75.5M Buy
6,111,000
+967,200
+19% +$11.2M 0.37% 63
2013
Q4
$56.4M Buy
5,143,800
+1,615,800
+46% +$18.2M 0.28% 74
2013
Q3
$40.9M Buy
3,528,000
+3,457,800
+4,926% +$40.5M 0.21% 114
2013
Q2
$786K Buy
+70,200
New +$831K ﹤0.01% 529

Other funds holding EW